WebJun 20, 2008 · Purpose: Higher plasma 25-hydroxyvitamin D(3) (25(OH)D) levels are associated with a decreased incidence of colorectal cancer, but the influence of plasma 25(OH)D on the outcome of patients with established colorectal cancer is unknown. Patients and methods: We prospectively examined the association between prediagnosis … WebOct 31, 2013 · J Clin Oncol. 2007;25:4779–86. Article CAS PubMed Google Scholar Pectasides D, Papaxoinis G, Kalogeras KT, et al. XELIRI-bevacizumab versus FOLFIRI …
FOLFIRI plus bevacizumab - UpToDate
WebMar 18, 2011 · Fuchs CS, Marshall J, Mitchell E et al (2007) Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C study. J Clin Oncol 25:4779–4786. Article PubMed CAS Google Scholar WebRougier P, Raoul J-L, Van Laethem J-L, et al. Cetuximab + FOLFIRI as first-line treatment for metastatic colorectal CA. J Clin Oncol 2004;22: Suppl: 248s-248s. Crossref; Web of Science; Google ... schema communication externe
Randomized, controlled trial of irinotecan plus infusional ... - PubMed
WebSep 17, 2012 · Fuchs CS, Marshall J, Mitchell E, et al. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. J Clin Oncol 2007 Oct 20; 25(30): 4779–86. Article PubMed CAS Google Scholar WebFeb 7, 2011 · This is the first phase II study to evaluate the efficacy and tolerability of the first-line FOLFIRI, as well as the influence of uridine di ... Including the Analysis of UGT1A1*28/*6 Polymorphisms, Japanese Journal of Clinical Oncology, Volume 41, Issue 4, ... (irinotecan 180 mg/m 2), 85.9% reported by Tournigand et al. ... WebMar 1, 2015 · Purpose: The phase III CRYSTAL study demonstrated that addition of cetuximab to fluorouracil, leucovorin, and irinotecan (FOLFIRI) significantly improved overall survival, progression-free survival, and objective response in the first-line treatment of patients with KRAS codon 12/13 (exon 2) wild-type metastatic colorectal cancer (mCRC). … schema contraction uterine